Maman Laminou Ibrahim
Overview
Explore the profile of Maman Laminou Ibrahim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ide Amadou H, Yoda H, Tialla D, Yanogo P, Barry D, Ibrahim M, et al.
Pan Afr Med J
. 2024 Jun;
47:117.
PMID: 38828421
On January 30, 2020, the WHO declared COVID-19 a global health emergency. Children were affected in less severe forms. Niger had implemented measures in a context where children were a...
2.
Mahaman Moustapha L, Adamou R, Ibrahim M, Abdoulaye Louis Padounou M, Diallo A, Courtin D, et al.
Malar J
. 2021 Jan;
20(1):1.
PMID: 33386070
Background: In endemic areas, children develop slowly and naturally anti-Plasmodium antibodies and become semi-immune. Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine + amodiaquine (SPAQ) is a new strategy to reduce malaria...
3.
Soumana A, Samaila A, Mahaman Moustapha L, Kamaye M, Daouda B, Alkassoum Salifou I, et al.
Case Rep Pediatr
. 2020 Oct;
2020:8847415.
PMID: 33014499
While there have been very few fatal cases, SARS-CoV-2 has been reported in paediatric patients. This study aims to describe a fatal case of COVID-19 in a child with severe...
4.
Ibrahim M, Sadou F, Daou M, Halima B, Abani M, Halima Z, et al.
Mali Med
. 2018 Aug;
31(1):1-7.
PMID: 30079656
Malaria is a major public health problem in Niger. The Global Fund to fight AIDS, Tuberculosis, and Malaria launched, in 2011, an initiative entitled "Affordable Medicines Facility - Malaria" or...
5.
Salissou A, Zamanka H, Biyghe Binze B, Riviere T, Tichit M, Ibrahim M, et al.
Malar Res Treat
. 2014 Dec;
2014:614190.
PMID: 25506465
Chloroquine (CQ) resistance is widespread in Africa, but few data are available for Niger. Pfcrt haplotypes (aa 56-118) and ex vivo responses to CQ and amodiaquine were characterized for 26...
6.
Ibrahim M, Steenkeste N, Khim N, Adam H, Konate L, Coppee J, et al.
Malar J
. 2009 Feb;
8:32.
PMID: 19236701
Background: Over the last years, significant progress has been made in the comprehension of the molecular mechanism of malaria resistance to drugs. Together with in vivo tests, the molecular monitoring...
7.
Ibrahim M, Khim N, Adam H, Ariey F, Duchemin J
Malar J
. 2009 Feb;
8:28.
PMID: 19226462
Background: Plasmodium falciparum resistance to drugs remains a major public health issue in Niger. The therapeutic failure index for chloroquine and sulphadoxine-pyrimethamine are, respectively 20% and 21.9%. In December 2005,...
8.
Ibrahim M, Gay-Andrieu F, Adehossi E, Lacroix V, Randrianarivelojosia M, Duchemin J
Microbes Infect
. 2007 Apr;
9(5):599-604.
PMID: 17409009
Drug resistance has been shown to increase malaria mortality and morbidity in both community- and hospital-based studies. We investigated the association between two Plasmodium falciparum drug resistance-related molecular markers and...
9.
Gay-Andrieu F, Adehossi E, Lacroix V, Gagara M, Ibrahim M, Kourna H, et al.
Malar J
. 2005 Feb;
4:10.
PMID: 15703076
Background: Malaria takes a heavy toll in Niger, one of the world's poorest countries. Previous evaluations conducted in the context of the strategy for the Integrated Management of Childhood Illness,...